AGP Picks
View all

Wyoming Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wyoming Tech Reporter.

Press releases published on May 27, 2026

LightTable Raises $22 Million Series A to Accelerate AI-Native Workflows for Design and Construction Teams
Interact Enters a New Era of Growth with Brand Evolution, AI Innovation, and Industry Recognition
Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences
Opus Genetics to Present at the 2026 Jefferies Global Healthcare Conference
Collegium to Participate in 2026 Jefferies Global Healthcare Conference
Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis
NordProtect opens a new chapter in product development and becomes Coveron
ViroMissile IDOV-Safe Phase 1 Data to Be Presented at the 2026 ASCO Annual Meeting
Formula5 Joins Microsoft Security Elite Partner Program to Advance Secure AI Adoption for Enterprise Clients
Avalyn to Participate in the Jefferies Global Healthcare Conference
Annexon to Participate in Upcoming June Investor Conferences
Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty
RemoFirst Goes All-In on AI, Becoming the First Major AI-Native Employer of Record and Launches RemoAI
Yodeck Partners with Screenfeed to Expand App Ecosystem with 30+ Apps
Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2
Prime Force Group Joins Vertesia’s Fast-Growing Partner Ecosystem
Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference
New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia
4DMT to Participate in Upcoming Investor Conferences
Rectify Pharmaceuticals Presents New Translational Data at EASL 2026 Supporting RTY-406, its Clinical Candidate for the Treatment of Primary Sclerosing Cholangitis

Share this page:

Sign up for:

Wyoming Tech Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.